A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with advanced or recurrent non-squamous non-small cell lung cancer

被引：0
|
作者：
Yabuki, Yohei [1 ]
Otsuka, Kenji [1 ]
Ogino, Hirokazu [1 ]
Takeuchi, Eiji [2 ]
Haku, Takashi [3 ]
Kanematsu, Takanori [4 ]
Nishimura, Naoki [5 ]
Toyoda, Yuko [6 ]
Hanibuchi, Masaki [7 ]
Mitsuhashi, Atsushi [1 ]
Tsukazaki, Yuki [1 ]
Ozaki, Ryohiko [1 ]
Yoneda, Hiroto [1 ]
Nokihara, Hiroshi [1 ]
Nisihioka, Yasuhiko [1 ]
机构：
[1] Tokushima Univ Hosp, Resp Med & Rheumatol, Tokushima, Japan
[2] Natl Hosp Org Kochi Hosp, Dept Clin Invest, Kochi, Japan
[3] Tokushima Prefectural Cent Hosp, Resp Med, Tokushima, Japan
[4] Japanese Red Cross Matsuyama Hosp, Resp Med, Matsuyama, Ehime, Japan
[5] St Lukes Int Hosp, Thorac Ctr, Tokyo, Japan
[6] Japanese Red Cross Kochi Hosp, Internal Med, Kochi, Japan
[7] Shikoku Cent Hosp, Resp Med, Matsuyama, Ehime, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP08-282
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [31] Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
    Fukushima, Toshirou
    Wakatsuki, Yuuki
    Kobayashi, Takashi
    Sonehara, Kei
    Tateishi, Kazunari
    Yamamoto, Manabu
    Masubuchi, Takeshi
    Yoshiike, Fumiaki
    Hirai, Kazuya
    Hachiya, Tsutomu
    Koizumi, Tomonobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1043 - 1050
  • [32] Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
    Toshirou Fukushima
    Yuuki Wakatsuki
    Takashi Kobayashi
    Kei Sonehara
    Kazunari Tateishi
    Manabu Yamamoto
    Takeshi Masubuchi
    Fumiaki Yoshiike
    Kazuya Hirai
    Tsutomu Hachiya
    Tomonobu Koizumi
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 1043 - 1050
  • [33] A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Tamiya, Akihiro
    Morimoto, Masahiro
    Fukuda, Shoichi
    Naoki, Yoko
    Ibe, Tatsuya
    Okishio, Kyoichi
    Goto, Hideto
    Yoshii, Akihiro
    Kita, Toshiyuki
    Nogami, Naoyuki
    Fujita, Yuka
    Atagi, Shinji
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 667 - 673
  • [34] A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Akihiro Tamiya
    Masahiro Morimoto
    Shoichi Fukuda
    Yoko Naoki
    Tatsuya Ibe
    Kyoichi Okishio
    Hideto Goto
    Akihiro Yoshii
    Toshiyuki Kita
    Naoyuki Nogami
    Yuka Fujita
    Shinji Atagi
    Investigational New Drugs, 2018, 36 : 667 - 673
  • [35] A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
    Hanibuchi, Masaki
    Kakiuchi, Soji
    Atagi, Shinji
    Ogushi, Fumitaka
    Shimizu, Eiji
    Haku, Takashi
    Toyoda, Yuko
    Azuma, Masahiko
    Kondo, Mayo
    Kawano, Hiroshi
    Otsuka, Kenji
    Sakaguchi, Satoshi
    Nokihara, Hiroshi
    Goto, Hisatsugu
    Nishioka, Yasuhiko
    LUNG CANCER, 2018, 125 : 93 - 99
  • [36] A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease
    Hanibuchi, M.
    Kakiuchi, S.
    Atagi, S.
    Ogushi, F.
    Shimizu, E.
    Haku, T.
    Toyoda, Y.
    Azuma, M.
    Kondo, M.
    Kawano, H.
    Otsuka, K.
    Sakaguchi, S.
    Nokihara, H.
    Goto, H.
    Nishioka, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S472 - S472
  • [37] ALK AND EGFR MUTATION ANALYSIS IN A PHASE II TRIAL OF CISPLATIN/PEMETREXED IN JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Yanagitani, N.
    Kaburaki, K.
    Ohyanagi, F.
    Kudo, K.
    Horiike, A.
    Motoi, N.
    Takeuchi, K.
    Ishikawa, Y.
    Horai, T.
    Nishio, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 418 - 418
  • [38] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC)
    Ding, Lingyu
    Liu, Kejun
    Jiang, Zhelong
    Chen, Qi
    Zhou, Ningning
    Liang, Ying
    Gao, Hongfei
    Hong, Xiangchan
    Wu, Haiying
    TUMOR BIOLOGY, 2015, 36 (04) : 2491 - 2499
  • [39] Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)
    Fukuda, Minoru
    Kitazaki, Takeshi
    Ogawara, Daiki
    Ichiki, Masao
    Mukae, Hiroshi
    Maruyama, Riichiroh
    Nakagaki, Noriaki
    Shimada, Midori
    Ikeda, Takaya
    Kishimoto, Junji
    Harada, Taishi
    Seto, Takashi
    Ebi, Noriyuki
    Takayama, Koichi
    Okamoto, Isamu
    Ichinose, Yukito
    Sugio, Kenji
    LUNG CANCER, 2019, 132 : 1 - 8
  • [40] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Yaru Tian
    Hairong Tian
    Xiaoyang Zhai
    Hui Zhu
    Jinming Yu
    Frontiers of Medicine, 2022, 16 : 610 - 617
12345